Quantification of visceral adipose tissue volume predicts both short-term and long-term transmural healing in patients with Crohn’s disease receiving Ustekinumab
Therapeutic Advances in Gastroenterology
Published online on March 16, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:Transmural healing (TH) is an emerging therapeutic target in Crohn’s disease (CD). Visceral adipose tissue (VAT) is associated with the prognosis of CD, but few studies investigate the ability of VAT in predicting TH.Objectives:We aimed to ...
Background:Transmural healing (TH) is an emerging therapeutic target in Crohn’s disease (CD). Visceral adipose tissue (VAT) is associated with the prognosis of CD, but few studies investigate the ability of VAT in predicting TH.Objectives:We aimed to ...